Evidence map›Paper›PMID 33193832›Full record

ArticleTherapeutic advances in musculoskeletal disease2020

Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting.

Benjamin Batteux, Valérie Gras-Champel, Mathilde Lando, François Brazier, Romuald Mentaverri, Isabelle Desailly-Henry, Amayelle Rey, Youssef Bennis, Kamel Masmoudi, Gabriel Choukroun and 1 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in musculoskeletal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Calcitriol supplementation after kidney transplantation: results of a double-blinded, randomized, placebo-controlled trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Natural History of Bone Disease following Kidney Transplantation.Journal of the American Society of Nephrology : JASN · 2022
    Observational
  8. Bone and Mineral Disease in Kidney Transplant Recipients.Clinical journal of the American Society of Nephrology : CJASN · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Benjamin BatteuxDepartment of Clinical Pharmacology, Amiens University Medical Center, Rue du Professeur Christian Cabrol, Amiens, 80054, France.ORCID https://orcid.org/0000-0001-9466-7110
Valérie Gras-ChampelRegional Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
Mathilde LandoDepartment of Nephrology Internal Medicine Dialysis Transplantation, Amiens University Medical Center, Amiens, France.
François BrazierDepartment of Nephrology Internal Medicine Dialysis Transplantation, Amiens University Medical Center, Amiens, France.
Romuald MentaverriMP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France.
Isabelle Desailly-HenryDepartment of Rheumatology, Amiens University Medical Center, Amiens, France.
Amayelle ReyRegional Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
Youssef BennisRegional Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
Kamel MasmoudiRegional Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
Gabriel ChoukrounMP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France.
Sophie LiabeufRegional Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
Centre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier de Saint-Quentin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term corticosteroid use after kidney transplantation is associated with a decrease in bone mineral density (BMD) and a high fracture risk. We hypothesized that patients with early steroid withdrawal (ESW) would display a gain in BMD in the year following kidney transplantation, when compared with patients on long-term corticosteroid therapy.

methodsIn a cohort of kidney transplant recipients, 356 patients were included between 2012 and 2019. Dual-energy X-ray absorptiometry was performed 1 and 12 months after transplantation. The data were analyzed using linear regression with inverse probability-of-treatment weighting (based on a propensity score).

resultsAt 1 year after transplantation, the gain in BMD was significantly greater in recipients with ESW than in recipients on long-term corticosteroid therapy for the lumbar spine (+0.036 g/cm

conclusionESW has a positive effect on bone in kidney transplant recipients.

Indexed as

bone mineral densityearly steroid withdrawalkidney transplantationosteoporosis

Identifiers

PMID33193832
PMCPMC7604996
OpenAlexW3097936065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.